Bladder cancer (BC) is the most common type of malignant tumor in the genitourinary system. Through the microarray analysis of clinical samples, long noncoding RNA HAND2-AS1 expression was found to be downregulated in BC tissues. However, the function of HAND2-AS1 on BC and underlying mechanism are unclear. In this study, the correlations of HAND2-AS1 with clinicopathological parameters in BC patients were determined. The gain- and loss-of-function experiments were conducted to examine the role of HAND2-AS1 in malignant behaviors of BC cells in vitro and in vivo. Then, we paid attention to miR-17-5p/KLF9 axis to illustrate the molecular mechanism. Results showed that HAND2-AS1 was downregulated in BC tissues, and its overexpression significantly inhibited cell proliferation, migration, and invasion in vitro, as well as tumor growth in vivo. Knockdown of HAND2-AS1 caused an opposite effect on BC cell malignancies. Furthermore, miR-17-5p was shown to be a direct target of HAND2-AS1, and it reversed the inhibitory effect of HAND2-AS1 on BC malignancies. Also, as a downstream factor of miR-17-5p, KLF9 silencing was demonstrated to mediate the role of miR-17-5p inhibitor in BC cell proliferation and invasion. Thus, it suggests that HAND2-AS1 acts as a suppressor in BC development through miR-17-5p/KLF9 axis.
Get full access to this article
View all access options for this article.
References
1.
BhanA., SoleimaniM., and MandalS.S. (2017). Long noncoding RNA and cancer: a new paradigm. Cancer Res, 77, 3965–3981.
2.
BrayF., FerlayJ., SoerjomataramI., SiegelR.L., TorreL.A., and JemalA. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68, 394–424.
3.
BrownA.R., SimmenR.C.M., RajV.R., VanT.T., MacLeodS.L., and SimmenF.A. (2015). Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis, 36, 946–955.
4.
ChenM., FanL., ZhangS.-M., LiY., ChenP., PengX., et al. (2019). LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression. Cell Death Dis, 10, 70.
5.
ChenS., and WangJ. (2019). HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1. Cancer Cell Int, 19, 353.
6.
DaC.-M., ChengZ.-Y., GongC.-Y., NanW., ZhouK.-S., ZhaoG.-H., et al. (2020). Role of HAND2-AS1 in human tumors. Clin Chim Acta, 511, 189–197.
7.
DellagoH., BobbiliM.R., and GrillariJ. (2017). MicroRNA-17-5p: at the crossroads of cancer and aging—a mini-review. Gerontology, 63, 20–28.
8.
DongW., BiJ., LiuH., YanD., HeQ., ZhouQ., et al. (2019). Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Mol Cancer, 18, 95.
9.
DuanB., ShiS., YueH., YouB., ShanY., ZhuZ., et al. (2019). Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI. J Cancer, 10, 6681–6692.
10.
HeQ., HuangL., YanD., BiJ., YangM., HuangJ., et al. (2019). CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9. Aging (Albany NY), 11, 11314–11328.
11.
JiangZ., LiL., HouZ., LiuW., WangH., ZhouT., et al. (2020). LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer. Cell Signal, 66, 109483.
12.
LenisA.T., LecP.M., ChamieK., and MshsM.D. (2020). Bladder cancer: a review. JAMA, 324, 1980–1991.
13.
LiG., KryczekI., NamJ., LiX., LiS., LiJ., et al. (2021). LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat Cell Biol, 23, 526–537.
14.
LiY., SunQ., JiangM., LiS., ZhangJ., XuZ., et al. (2019). KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28. FASEB J, 33, 7915–7928.
15.
Martens-UzunovaE.S., BöttcherR., CroceC.M., JensterG., VisakorpiT., and CalinG.A. (2014). Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol, 65, 1140–1151.
16.
PatelV.G., OhW.K., and GalskyM.D. (2020). Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin, 70, 404–423.
17.
PengH., and LiH. (2019). The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis. Mol Carcinog, 58, 1465–1480.
18.
ShanL., LiuW., and ZhanY. (2021). LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146. Cancer Cell Int, 21, 361.
19.
SiegelR.L., MillerK.D., FuchsH.E., and JemalA. (2021). Cancer statistics, 2021. CA Cancer J Clin, 71, 7–33.
20.
SjödahlG., LaussM., LövgrenK., ChebilG., GudjonssonS., VeerlaS., et al. (2012). A molecular taxonomy for urothelial carcinoma. Clin Cancer Res, 18, 3377–3386.
21.
SuY., FengW., ShiJ., ChenL., HuangJ., and LinT. (2020). circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway. Mol Cancer, 19, 23.
22.
SunJ., WangB., LiuY., ZhangL., MaA., YangZ., et al. (2014). Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression. Cancer Lett, 355, 25–33.
23.
WangY., MaM., LiC., YangY., and WangM. (2021). GAS6-AS1 overexpression increases GIMAP6 expression and inhibits lung adenocarcinoma progression by sponging miR-24-3p. Front Oncol, 11, 645771.
24.
WangY., ZhuP., LuoJ., WangJ., LiuZ., WuW., et al. (2019). LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling. EMBO J, 38, e101110.
25.
XuJ., MengQ., LiX., YangH., XuJ., GaoN., et al. (2019). Long noncoding RNA MIR17HG promotes colorectal cancer progression via miR-17-5p. Cancer Res, 79, 4882–4895.
26.
XuM., CuiR., YeL., WangY., WangX., ZhangQ., et al. (2021). LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Mol Ther Nucleic Acids, 26, 280–294.
27.
YanD., JinF., and LinY (2020). lncRNA HAND2-AS1 inhibits liver cancer cell proliferation and migration by upregulating SOCS5 to inactivate the JAK-STAT pathway. Cancer Biother Radiopharm, 35, 143–152.
28.
YangC., YuanW., YangX., LiP., WangJ., HanJ., et al. (2018). Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer, 17, 19.
29.
ZhengR., DuM., WangX., XuW., LiangJ., WangW., et al. (2018). Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer, 17, 143.
30.
ZhongZ., ZhouF., WangD., WuM., ZhouW., ZouY., et al. (2018). Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines. Oncol Rep, 40, 3852–3860.
31.
ZhuangC., MaQ., ZhuangC., YeJ., ZhangF., and GuiY. (2019). LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC. FASEB J, 33, 11045–11059.
